Get started
Live feed
·
INSIDERFilingvia Quantisnow
Silexion Therapeutics Corp logo

Director Abramov Dror Yosef was granted 794 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Silexion Therapeutics Corp logo
SLXN
Silexion Therapeutics Corp
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for SLXN

Follow SLXN and get a push notification the moment its next story breaks.

Full SLXN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLXN (Silexion Therapeutics Corp) and more on Quantisnow.